Call For Czech Health Minister To Resign

6 February 1995

In a letter to the President, Vaclav Havel, the Czech Patients' Association has called on Health Minister Ludek Rubas to resign because it claims that the Minister has taken "unconsidered decisions" that have brought the health service to a point of collapse and badly affected health care, according to the CTK news agency's Business News.

Zdenek Mambalek, the association's chairman, says the organization has called on patients to withhold one month's health insurance payments if Mr Rubas does not resign by the end of February. Mr Hamalek added that the protest action should restore professionalism to Czech medicine, and said that Mr Rubas "no longer represents anybody."

The Association of Medical Professions in the Czech Republic has also taken action, breaking off contacts with the Ministry because of disagreements pertaining to regulations on health insurance. These disagreements are believed to focus on the extent of health care that will be funded by health insurance schemes.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight